InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Belvin Marcia. Director active across 1 company, notably CytomX Therapeutics, Inc.. Aggregated, 13 filings have been recorded. Split: 0 buy · 4 sells. Total volume traded: €216k. Activity tracked since 22 March 2023. The latest transaction was filed on 17 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
BELVIN MARCIA is a declarant linked to CytomX Therapeutics, Inc. The record shows 13 filings in total, and among the recent sampled filings they cover the period from 2023-03-29 to 2026-03-19, with EUR 0 in buys and EUR 216265 in sells, and the stated transaction nature is Attribution.